RHYTHM PHARMACEUTICALS, INC. (RYTM) › Net IncomeRHYTHM PHARMACEUTICALS, INC. (RYTM) — Net IncomeAnnual figures by fiscal year, from SEC filings.2015: -$11.07M2016: -$25.87M2017: -$33.71M2018: -$74.06M2019: -$140.73M2020: -$134.00M2021: -$69.61M2022: -$181.12M2023: -$184.68M2024: -$260.60M2025: -$196.54M-$196.54M2015Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$196.54M+24.6%2024-$260.60M-41.1%2023-$184.68M-2.0%2022-$181.12M-160.2%2021-$69.61M+48.0%2020-$134.00M+4.8%2019-$140.73M-90.0%2018-$74.06M-119.7%2017-$33.71M-30.3%2016-$25.87M-133.6%2015-$11.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share